山东药玻：2025年前三季度净利润约5.42亿元

Group 1 - Shandong Pharmaceutical Glass reported a revenue of approximately 3.401 billion yuan for the first three quarters of 2025, a year-on-year decrease of 11.1% [1] - The net profit attributable to shareholders of the listed company was approximately 542 million yuan, reflecting a year-on-year decline of 24.7% [1] - As of the report date, Shandong Pharmaceutical Glass had a market capitalization of 14.1 billion yuan [1]